Catalyst Wire Dossier Catalyst Wire Dossier

Grasustek

pegfilgrastim · Juta Pharma GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Grasustek, covering 2026-03-24 to 2026-06-15. Get the full timeline:

Most recent: EMA Authorised: Grasustek (pegfilgrastim) — Juta Pharma GmbH

See pricing